Leroux-Roels G - Search Results

1

Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus.

Meuleman P, Libbrecht L, Wieland S, De Vos R, Habib N, Kramvis A, Roskams T, Leroux-Roels G. Meuleman P, et al. J Virol. 2006 Mar;80(6):2797-807. doi: 10.1128/JVI.80.6.2797-2807.2006. J Virol. 2006. PMID: 16501088 Free PMC article.

2

Murine IL-2 receptor beta chain blockade improves human leukocyte engraftment in SCID mice.

Tournoy KG, Depraetere S, Meuleman P, Leroux-Roels G, Pauwels RA. Tournoy KG, et al. Eur J Immunol. 1998 Oct;28(10):3221-30. doi: 10.1002/(SICI)1521-4141(199810)28:10<3221::AID-IMMU3221>3.0.CO;2-S. Eur J Immunol. 1998. PMID: 9808191 Free article.

3

Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titers.

Depraetere S, Van Kerschaever E, Van Vlierberghe H, Elewaut A, Brouwer JT, Niesters HG, Schalm SW, Maertens G, Leroux-Roels G. Depraetere S, et al. J Med Virol. 2000 Feb;60(2):126-32. J Med Virol. 2000. PMID: 10596010 Clinical Trial.

4

Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.

Cao T, Lazdina U, Desombere I, Vanlandschoot P, Milich DR, Sällberg M, Leroux-Roels G. Cao T, et al. J Virol. 2001 Jul;75(14):6359-66. doi: 10.1128/JVI.75.14.6359-6366.2001. J Virol. 2001. PMID: 11413302 Free PMC article.

5

Prevention of hepatitis B infections: vaccination and its limitations.

Leroux-Roels G, Cao T, De Knibber A, Meuleman P, Roobrouck A, Farhoudi A, Vanlandschoot P, Desombere I. Leroux-Roels G, et al. Acta Clin Belg. 2001 Jul-Aug;56(4):209-19. doi: 10.1179/acb.2001.032. Acta Clin Belg. 2001. PMID: 11603250 Review.

6

In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.

Cao T, Meuleman P, Desombere I, Sällberg M, Leroux-Roels G. Cao T, et al. J Virol. 2001 Dec;75(23):11449-56. doi: 10.1128/JVI.75.23.11449-11456.2001. J Virol. 2001. PMID: 11689626 Free PMC article.

7

Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.

Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G. Vanlandschoot P, et al. J Gen Virol. 2002 Jun;83(Pt 6):1281-1289. doi: 10.1099/0022-1317-83-6-1281. J Gen Virol. 2002. PMID: 12029142

8

LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles.

Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Stelter F, Peterson DL, Gomez-Gutierrez J, Gavilanes F, Leroux-Roels G. Vanlandschoot P, et al. J Gen Virol. 2002 Sep;83(Pt 9):2279-2289. doi: 10.1099/0022-1317-83-9-2279. J Gen Virol. 2002. PMID: 12185283

9

Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B.

Cao T, Desombere I, Vanlandschoot P, Sällberg M, Leroux-Roels G. Cao T, et al. J Gen Virol. 2002 Dec;83(Pt 12):3023-3033. doi: 10.1099/0022-1317-83-12-3023. J Gen Virol. 2002. PMID: 12466479

10

Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?

Vanlandschoot P, Leroux-Roels G. Vanlandschoot P, et al. Trends Immunol. 2003 Mar;24(3):144-7. doi: 10.1016/s1471-4906(03)00026-7. Trends Immunol. 2003. PMID: 12615210 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

320 results

Search Page

Filters